Protagonist Therapeutics

Donated human blood conservation in a hospital
Biotech

Merck mulls PV program’s future while Takeda takes victory lap

Merck revealed the first look at data from a phase 2 trial of bomedemstat, while Takeda shared updated results from rusfertide's phase 3 study.
Darren Incorvaia Dec 8, 2025 4:30pm
An open book with pages turning on a wooden table set

J&J eyes takeover of immunology partner Protagonist: WSJ

Oct 10, 2025 2:30pm
crown royalty king queen win

J&J's IL-23 drug defeats Sotyktu in phase 3 psoriasis trial

Sep 17, 2025 9:45am
bubbles on a pink background

At ASCO, execs see chance to ‘rewrite textbooks’ in cancer care

Jun 2, 2025 9:45am
scrabble tiles spelling out psoriasis

J&J, Protagonist's oral psoriasis prospect bests BMS' Sotyktu

Mar 10, 2025 7:30am
Graphic of a drop of blood made up of small data points and nodes

Takeda's $300M bet on Protagonist's blood cancer drug pays off

Mar 3, 2025 8:45am